HIV Drugs May Increase Risk Of Heart Attack: FDA

Law360, New York (March 28, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration has revealed that two anti-HIV drugs, Ziagen and Videx, may lead to an increased risk of heart attack in patients.

In an early communication published Thursday, the FDA said that data collected from a large study had shown GlaxoSmithKline’s Ziagen and Bristol-Myers Squibb Co.’s Videx may increase the risk of heart attack by as much as 90% while patients are taking the drugs.

The study, called The Data Collection on Adverse Events of Anti-HIV Drugs Study observed more than 33,000...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.